Clinical Trials Browser

Phase 2 × Unknown × Carcinoma, Renal Cell × Clear all

NCT04387500 2024-04-09

Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma

Phase 2 Unknown

Fumaric aciduria, Carcinoma, Renal Cell

NCT06129955 2023-11-13

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

Phase 2 Unknown

Carcinoma, Renal Cell

NCT03961698 2023-08-14

MARIO-3

Phase 2 Unknown

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT05879471 2023-07-24

68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Phase 2 Unknown

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT05879497 2023-07-13

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Phase 2 Unknown

Carcinoma, Renal Cell

NCT05879510 2023-07-13

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Phase 2 Unknown

Carcinoma, Renal Cell

NCT05902377 2023-06-15

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Phase 2 Unknown

Carcinoma, Renal Cell

NCT03741426 2023-06-07

WIRE

Phase 2 Unknown

Carcinoma, Renal Cell

NCT03280667 2023-03-29

KEYPAD

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT02613819 2022-11-18

FASTRACK II

Phase 2 Unknown

Carcinoma, Renal Cell

NCT04913025 2022-09-21

REFINE

Phase 2 Unknown

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT03827837 2022-07-01

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Phase 2 Unknown

GenitourinaryGynecologic

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03177239 2022-02-16

UNISoN

Phase 2 Unknown

Carcinoma, Renal Cell

NCT02689167 2021-11-29

SURF

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT05124431 2021-11-18

ALTER-UC-001

Phase 2 Unknown

Carcinoma, Renal Cell

NCT01444807 2021-09-17

Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases

Phase 2 Unknown

Carcinoma, Renal Cell

NCT04534998 2021-09-13

ROBOCOP

Phase 2 Unknown

Carcinoma, Renal Cell

NCT04995016 2021-08-06

PANDORA

Phase 2 Unknown

Carcinoma, Renal Cell

NCT04958473 2021-07-12

SAARCC

Phase 2 Unknown

Carcinoma, Renal Cell

NCT04718584 2021-01-22

the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors

Phase 2 Unknown

Urinary Bladder Neoplasms, Carcinoma, Renal Cell

NCT04714697 2021-01-19

Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma

Phase 2 Unknown

Carcinoma, Renal Cell

NCT04134182 2020-12-23

Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.

Phase 2 Unknown

Carcinoma, Renal Cell

NCT04644432 2020-11-25

INDIGO

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms, Urologic Neoplasms

NCT03987698 2020-07-07

Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma

Phase 2 Unknown

Carcinoma, Renal Cell

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Phase 2 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04146831 2020-05-12

Sintilimab in FH-deficient Renal Cell Carcinoma

Phase 2 Unknown

Carcinoma, Renal Cell

NCT03592199 2019-09-04

SuAx

Phase 2 Unknown

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT04049344 2019-08-08

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Phase 2 Unknown

Carcinoma, Renal Cell

NCT03341845 2018-05-21

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

Phase 2 Unknown

Carcinoma, Renal Cell

NCT02072044 2017-12-29

Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy

Phase 2 Unknown

Carcinoma, Renal Cell

NCT02330783 2017-05-09

Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients

Phase 2 Unknown

Carcinoma, Renal Cell

NCT02774200 2016-05-17

A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.

Phase 2 Unknown

Carcinoma, Renal Cell

NCT02398552 2016-03-01

A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.

Phase 2 Unknown

Carcinoma, Renal Cell

NCT01791387 2015-02-03

DILIGENCE-1

Phase 2 Unknown

Carcinoma, Carcinoma, Renal Cell, Neoplasms

NCT02324803 2014-12-24

Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients

Phase 2 Unknown

Carcinoma, Renal Cell, Drug-Related Side Effects and Adverse Reactions

NCT01274273 2014-12-02

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell

NCT01577784 2014-03-12

Pazopanib in Second-line Therapy in Renal Cell Carcinoma

Phase 2 Unknown

Carcinoma, Renal Cell

NCT00301990 2014-01-10

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00717587 2014-01-10

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00030888 2014-01-06

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00002846 2013-12-19

Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00002847 2013-12-19

Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00080977 2013-12-19

High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00093522 2013-12-19

Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00002589 2013-12-18

Lymphocyte Therapy in Treating Patients With Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003181 2013-12-04

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003604 2013-11-06

Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003664 2013-11-06

Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00005038 2013-09-20

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms